Drug Type Protein drugs |
Synonyms |
Target |
Mechanism TrpRS inhibitors(tryptophanyl-tRNA synthetase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization MirimGENE Co. Ltd.Startup |
Active Organization MirimGENE Co. Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tuberculosis | Preclinical | KR | MirimGENE Co. Ltd.Startup | 25 May 2024 |